Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 207-668-4 | CAS number: 488-10-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin irritation (no guideline stated), rabbits and guinea pigs: irritating to skin
Eye irritation (no guideline stated), rabbits: irritating to eyes
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- April 1977
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: One page summary, no guideline included and study not GLP.
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- No guideline followed
- GLP compliance:
- no
- Species:
- rabbit
- Strain:
- not specified
- Type of coverage:
- not specified
- Preparation of test site:
- not specified
- Vehicle:
- not specified
- Controls:
- not specified
- Duration of treatment / exposure:
- No data
- Observation period:
- 14 days
- Number of animals:
- 10
- Remarks on result:
- other: substance is an irritant
- Irritation parameter:
- edema score
- Basis:
- other: all
- Time point:
- 14 d
- Reversibility:
- not specified
- Remarks on result:
- other: moderate in 10
- Irritation parameter:
- other: redness
- Basis:
- other: all
- Time point:
- 14 d
- Reversibility:
- not specified
- Remarks on result:
- other: moderate in 1, severe in 9
- Irritation parameter:
- erythema score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Reversibility:
- not specified
- Remarks on result:
- not measured/tested
- Irritation parameter:
- edema score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Reversibility:
- not specified
- Remarks on result:
- not measured/tested
- Interpretation of results:
- irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Jasmone-Cis is irritating.
- Executive summary:
Jasmone-Cis is irritating.
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1977
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study has no guideline and not conducted to GLP standards.
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- No guideline described in the attached test report.
- GLP compliance:
- no
- Species:
- guinea pig
- Strain:
- not specified
- Type of coverage:
- open
- Preparation of test site:
- clipped
- Vehicle:
- water
- Controls:
- yes
- Duration of treatment / exposure:
- 24 hours
- Observation period:
- 21 days
- Number of animals:
- 1-6 experimental groups
- Remarks on result:
- other: Substance is an irritant
- Irritation parameter:
- other: Irritation
- Basis:
- other: not specified
- Time point:
- other: 7d/14d/21d
- Reversibility:
- not specified
- Remarks on result:
- other: no score measured
- Irritation parameter:
- erythema score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Remarks on result:
- not measured/tested
- Irritation parameter:
- edema score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Remarks on result:
- not measured/tested
- Irritant / corrosive response data:
- 100 % irritant effects , skin effects, slight irritation was observed at the 7 day reading. Moderate irritation was observed at the 14 day reading. Strong irritation was observed at the 21 day reading.
30 % irritant effects , skin effects, slight irritation was observed at the 7 and 14 day reading. Moderate irritation was observed at the 21 day reading.
10 % irritant effects , skin effects, very slight irritation was observed at the 7 and 14 day reading. Slight irritation was observed at the 21 day reading.
3 % irritant effects , skin effects, no skin irritation was observed at the 7 and 14 day reading. Very slight skin irritation was observed at the 21 day reading. - Interpretation of results:
- irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Jasmone-Cis, as determined by the attached study report, is concluded to be a skin irritant.
- Executive summary:
Jasmone-Cis, as determined by the attached study report, is concluded to be a skin irritant.
Referenceopen allclose all
5 g/kg irritant effects.
Moderate redness in 1, severe redness in 9 and moderate edema in all 10.
Bleeding at exposure site in 1, slight eschar in 2, heavy eschar in 1 and severe escar in 1.
Substance is an irritant.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Report contains tabulated results only. The study was conducted prior to introduction of GLP and current test guidelines.
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The study was conducted prior to development of current guidelines. Reporting of the methodology is poor; the study does not appear to conform to current guidelines but generally follows the method of Draize - irritation was assessed following a single application, and following 7 daily applications.
- GLP compliance:
- no
- Remarks:
- Conducted prior to development of GLP
- Species:
- rabbit
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- Rabbits were used, no further information is provided
- Vehicle:
- other: Neantime; diethyl benzene-1,2-dicarboxylate
- Controls:
- yes, concurrent vehicle
- Amount / concentration applied:
- Test concentrations for the single application were 100%, 30%, 10%, 3% and 1%
Test concentrations for the repeat applications were 10%, 3% and 1% (based on results obtained in the single application study).
The vehicle used was neantime. - Duration of treatment / exposure:
- The irritation was assessed following a single application of the test substance initially and then proceeded to repeated application for 7 consecutive days.
- Observation period (in vivo):
- Observations were made for 7 days after the last application
- Number of animals or in vitro replicates:
- No information provided
- Details on study design:
- Irritation was scored according to the following system:
- = no reaction
(+) = slight redness
+ = moderate redness and secretion
++ = strong redness and strong secretion
+++ = strong redness and strong secretion and oedema - Irritation parameter:
- overall irritation score
- Basis:
- mean
- Time point:
- 24 h
- Reversibility:
- not specified
- Remarks on result:
- positive indication of irritation
- Remarks:
- Based on the results provided on the irritation test on the rabbit eye, it is concluded that this substance does cause eye irritation at 3%.
- Irritation parameter:
- overall irritation score
- Basis:
- mean
- Time point:
- 48 h
- Reversibility:
- not specified
- Remarks on result:
- positive indication of irritation
- Remarks:
- Based on the results provided on the irritation test on the rabbit eye, it is concluded that this substance does cause eye irritation at 100%.
- Irritation parameter:
- overall irritation score
- Basis:
- mean
- Time point:
- 72 h
- Reversibility:
- not specified
- Remarks on result:
- positive indication of irritation
- Remarks:
- Based on the results provided on the irritation test on the rabbit eye, it is concluded that this substance does cause eye irritation at 100%.
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Reversibility:
- not specified
- Remarks on result:
- not measured/tested
- Irritation parameter:
- iris score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Reversibility:
- not specified
- Remarks on result:
- not measured/tested
- Remarks:
- not specified
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Reversibility:
- not specified
- Remarks on result:
- not measured/tested
- Remarks:
- not specified
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Reversibility:
- not specified
- Remarks on result:
- not measured/tested
- Remarks:
- not specified
- Irritant / corrosive response data:
- Single application: no reactions were observed following treatment with the 1% concentration. Treatment with 3% caused slight redness 1 day after application that had completely resolved by day 2. Treatment with 30% caused moderate redness and secretion 1 day after application, which reduced to slight redness 2 days after application. Signs of irritation had resolved by Day 3. Treatment with the undiluted test substance caused strong redness, strong secretion and oedema 1 day after application; signs of irritation ameliorated from then on and eyes were completely free of irritation by Day 6.
Repeat applications: no reactions were observed following 7 days repeat exposure to the 1% concentration. 7 days repeat treatment with the 3% and 10% concentrations resulted in slight redness at each observation, which persisted to study termination on Day 7.
The vehicle (neantime) was reported to have a highest non-irritant concentration of 10% following single application, and 100% following repeat application. - Other effects:
- No other effects reported.
- Interpretation of results:
- irritating
- Remarks:
- Migrated information at 3% concentration Criteria used for interpretation of results: EU
- Conclusions:
- Based on the results provided on the irritation test on the rabbit eye, it is concluded that this substance does cause eye irritation at 3%.
- Executive summary:
The eye irritation potential of Jasmone was evaluated in rabbits. A single application was made to the rabbit eye at concentrations of 100%, 30%, 10%, 3% and 1% (in neantime). Signs of irritation were recorded daily for 7 days after application. In addition, concentrations of 10%, 3% and 1% were applied daily for 7 days and signs of irritation recorded daily for 7 days after the last application. A single application of 3, 10 or 30% test substance caused slight redness (erythema) which resolved by Day 2. No irritant reactions were observed following treatment with 1%. A single application of 100% test substance caused strong redness (erythema), secretion and oedema; symptoms reduced over the following days and eyes were free from irritation by Day 6. Repeated application with 1% test substance caused no adverse effects. Slight redness (erythema) was observed following 7 -days repeat application with 3% and 10% test substance; effects persisted to study termination (7 days after the last application). The vehicle (neantime) was reported to have a highest non-irritant concentration of 10% following single application, and 100% following repeat application.
It was concluded that the highest non-irritating concentration of the test substance was 1%, and the lowest irritant concentration was 3%.
Reference
A: Single application:
Substance |
Lowest irritant concentration |
Highest non-irritant concentration |
Giv 1-0985 Ro 6-8198 |
3% |
1% |
Solvent |
- |
10% |
Duration of the lesions:
Substance |
Concentration % |
Day 1 |
Day 2 |
Day 3 |
Day 4 |
Day 5 |
Day 6 |
Day 7 |
Giv 1-0985 Ro 6-8198 |
100 |
+++ |
++ |
+ |
(+) |
(+) |
- |
- |
30 |
+ |
(+) |
- |
- |
- |
- |
- |
|
10 |
(+) |
- |
- |
- |
- |
- |
- |
|
3 |
(+) |
- |
- |
- |
- |
- |
- |
|
1 |
- |
- |
- |
- |
- |
- |
- |
|
Solvent |
100 |
- |
- |
- |
- |
- |
- |
- |
Evaluation:
- = No reaction
(+) = Slight redness
+ = Slight redness and secretion
++ = Moderate redness and strong secretion
+++ = Strong redness and strong secretion and oedema
B: Repeated application on 7 consecutive days-Score after last application:
Substance |
Lowest irritant concentration |
Highest non-irritant concentration |
Giv 1-0985 Ro 6-8198 |
3% |
1% |
Solvent |
- |
10% |
Substance |
Concentration % |
Day 1 |
Day 2 |
Day 3 |
Day 4 |
Day 5 |
Day 6 |
Day 7 |
Giv 1-0985 Ro 6-8198 |
100 |
Not done |
|
|
|
|
|
|
30 |
Not done |
|
|
|
|
|
|
|
10 |
(+) |
(+) |
(+) |
(+) |
(+) |
(+) |
(+) |
|
3 |
(+) |
(+) |
(+) |
(+) |
(+) |
(+) |
(+) |
|
1 |
- |
- |
- |
- |
- |
- |
- |
|
Solvent |
100 |
- |
- |
- |
- |
- |
- |
- |
Evaluation:
- = No reaction
(+) = Slight redness
+ = Slight redness and secretion
++ = Moderate redness and strong secretion
+++ = Strong redness and strong secretion and oedema
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
- Test item concentration 100 % (undiluted): slight irritation at the 7 day reading, moderate irritation at the 14 day reading and strong irritation at the 21 day reading.
- Test item concentration 30 %: slight irritation at the 7 and 14 day readings and moderate irritation at the 21 day reading.
- Test item concentration 10 %: very slight irritation at the 7 and 14 day readings and slight irritation at the 21 day reading.
- Test item concentration 3 %: no skin effects at the 7 and 14 day readings and very slight skin irritation at the 21 day reading.
Skin irritation / corrosion
There are two investigations of the skin irritation / corrosion potential of the registered substance available. The first study is properly reported and is therefore considered reliable with restrictions (Klimisch score 2), while the second one is only a short summary and hence its reliability cannot be assigned (Klimisch score 4). However, the results obtained are consistent and confirm irritating properties. Both studies are therefore taken into account by means of a Weight-of-Evidence approach.
cis-Jasmone has been tested for its skin irritation potential in an open epicutaneous test (Giv, 1977; no guideline stated; no GLP). The test consisted of two experiments. While the purpose of the first experiment was to establish the lowest irritating and the highest non irritating concentration, the second experiment investigated effects on skin after repeated exposure to the test substance.
In the first experiment test material concentrations of 100%, 30%, 10%, 3% in acetone were applied to the clipped flanks of 6 to 8 guinea pigs per concentration under open conditions. A single application of 0.025 ml of each test concentration was performed and skin reactions were read 24 h after the application of the test material. The lowest irritating and the highest non irritating concentrations were determined by an all-or-none criterion. The lowest irritating concentration is defined as the lowest concentration causing skin irritation. The highest non irritating concentration is defined as the highest one not causing macroscopic skin reactions in any of the animals. The minimal irritant concentration was established at 10% and the highest non irritant concentration at 3% by visual inspections of all animals.
On day zero of the second experiment, 0.1 ml of the undiluted test material and its progressively diluted solutions (concentrations of 30%, 10% and 3%) was applied to an area measuring 8 cm2 on the clipped flank of 6 to 8 guinea pigs per concentration group. The applications were repeated daily for 3 weeks or were done 5 times/week during a period of 4 weeks, always using the same skin site. The application site was left uncovered and the reactions were read 24 h after each application or at the end of each week. After exposure to the test substance for 21 consecutive days, the following skin reactions were observed:
The results of both experiments clearly indicate a skin irritating potential of the test substance.
Observations of skin reactions were also made in an acute dermal toxicity study (Givaudan, 1977; no GLP). A group of 10 rabbits (no further details given in study report) were exposed to 5000 mg/kg bw of the test item and observed for a period of 14 days. At the end of the test moderate redness was apparent in 1/10 and severe redness in 9/10 animals and moderate edema occurred in all 10 animals. In addition, bleeding at exposure site was observed in 1/10, slight eschar in 2/20, heavy eschar in 1/10 and severe eschar in 1/10 of the test animals. The test substance was therefore considered to be irritating to skin.
Eye irritation
The eye irritation potential of cis-Jasmone was evaluated in rabbits (Roche, 1971; no guideline stated; no GLP). A single application of the test substance was made to the rabbit eyes at concentrations of 100%, 30%, 10%, 3% and 1% (in Neantine as solvent). Signs of irritation were recorded daily for 7 days after application. In addition, concentrations of 10%, 3% and 1% were applied daily for 7 days and signs of irritation recorded daily for 7 days after the last application. A single application of 3, 10 or 30% test substance caused slight redness (erythema) which resolved by Day 2. No irritant reactions were observed following treatment with 1%. A single application of 100% test substance caused strong redness (erythema), secretion and oedema; symptoms reduced over the following days and eyes were free from irritation by Day 6. Repeated application with 1% test substance caused no adverse effects. Slight redness (erythema) was observed following 7 days repeat application with 3% and 10% test substance; effects persisted to study termination (7 days after the last application). The vehicle (Neantine) was reported to have a highest non-irritant concentration of 10% following single application, and 100% following repeat application. It was concluded that the highest non-irritating concentration of the test substance was 1%, and the lowest irritant concentration was 3%. Overall, the test substance was considered to be irritating to eyes.
Conclusion
In all available studies investigating the irritation potential of cis-Jasmone, skin and eye effects have not been scored according to a recognised scheme, e.g. the Draize scoring scheme, but only qualitative descriptions of skin and eye reactions are given. However, the qualitative descriptions are comparable to the parameters of current test guidelines and accepted classification criteria. The validity of the data is also underlined by the fact that all results are consistent, clearly reflecting an irritation potential for skin and eyes. Although individual study reports might not meet acceptance criteria, all studies taken together in a Weight-of-Evidence approach, result in a unanimous characterisation of the irritation properties of cis-Jasmone. Therefore, the data provided is deemed sufficient to establish a reliable classification with regard to skin irritation / corrosion and eye irritation.
Justification for classification or non-classification
The available data on skin and eye irritation are suitable to derive a classification and labelling. The available data meet the criteria for classification for Skin irrit. 2, H315, and Eye irrit. 2, H319, according to Regulation (EC) No. 1272/2008 (CLP) and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.